Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Regan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 1, 1993
Reasons for admission among six profile subgroups of recidivists of inpatient servicesE S Casper, J R Regan
Military Medicine|January 1, 1988
Adenocarcinoma of the lung presenting as hematemesis secondary to jejunal metastasis: a case report and review of the literatureJ R Regan, R B Gibbons
Hospital & Community Psychiatry|January 1, 1992
Frequent-user subgroupsE S Casper, J R Regan
Tennessee Medicine : Journal of the Tennessee Medical Association|August 11, 1998
Tennessee targeting strategies to address coexisting disordersM L Hampton, S W Perry, J R Regan
Cardiovascular and Interventional Radiology|May 11, 1992
Spontaneous splenic rupture associated with thrombolytic therapy and/or concomitant heparin anticoagulationG W Lambert, P S Cook, G A Gardiner, et al.
Surgical Laparoscopy & Endoscopy|October 1, 1995
Anterior thoracic corpectomy for spinal cord decompression performed endoscopicallyP C McAfee, J R Regan, I L Fedder, et al.
Spine|July 15, 1995
The incidence of complications in endoscopic anterior thoracolumbar spinal reconstructive surgery. A prospective multicenter study comprising the first 100 consecutive casesP C McAfee, J R Regan, T Zdeblick, et al.
Pharmacology|January 1, 1993
RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agentD Amin, S K Gustafson, J M Weinacht, et al.
Journal of Medicinal Chemistry|June 1, 1990
Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensivesJ J Mencel, J R Regan, J Barton, et al.
Journal of Medicinal Chemistry|June 1, 1990
Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activityJ N Barton, J J Piwinski, J W Skiles, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 1, 1993
Reasons for admission among six profile subgroups of recidivists of inpatient servicesE S Casper, J R Regan
Military Medicine|January 1, 1988
Adenocarcinoma of the lung presenting as hematemesis secondary to jejunal metastasis: a case report and review of the literatureJ R Regan, R B Gibbons
Hospital & Community Psychiatry|January 1, 1992
Frequent-user subgroupsE S Casper, J R Regan
Tennessee Medicine : Journal of the Tennessee Medical Association|August 11, 1998
Tennessee targeting strategies to address coexisting disordersM L Hampton, S W Perry, J R Regan
Cardiovascular and Interventional Radiology|May 11, 1992
Spontaneous splenic rupture associated with thrombolytic therapy and/or concomitant heparin anticoagulationG W Lambert, P S Cook, G A Gardiner, et al.
Surgical Laparoscopy & Endoscopy|October 1, 1995
Anterior thoracic corpectomy for spinal cord decompression performed endoscopicallyP C McAfee, J R Regan, I L Fedder, et al.
Spine|July 15, 1995
The incidence of complications in endoscopic anterior thoracolumbar spinal reconstructive surgery. A prospective multicenter study comprising the first 100 consecutive casesP C McAfee, J R Regan, T Zdeblick, et al.
Pharmacology|January 1, 1993
RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agentD Amin, S K Gustafson, J M Weinacht, et al.
Journal of Medicinal Chemistry|June 1, 1990
Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensivesJ J Mencel, J R Regan, J Barton, et al.
Journal of Medicinal Chemistry|June 1, 1990
Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activityJ N Barton, J J Piwinski, J W Skiles, et al.
Pageof 2